|Articles|March 15, 2005

2005 ACT Directory and Buyers Guide

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition

ByAndy Studna, Senior Editor

October 23rd 2025

© Pixel-Shot - © Pixel-Shot - stock.adobe.com

Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema

ByAndy Studna, Senior Editor

October 22nd 2025

A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025

ByRajneesh Patil,Drew Garty,Andy Studna, Senior Editor

October 22nd 2025

ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer

ByAndy Studna, Senior Editor

October 22nd 2025

Honing the Power of AI for Next Generation Trial Oversight and Execution

ByRichard Young

October 21st 2025

2005 ACT Directory and Buyers Guide

Newsletter

Related Content

ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition

Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema

A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025

ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer

Honing the Power of AI for Next Generation Trial Oversight and Execution

Trending on Applied Clinical Trials Online

Honing the Power of AI for Next Generation Trial Oversight and Execution

A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025

ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer

Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema